SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
+0.83%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$173M
(+14%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
47.24%
Holding
102
New
27
Increased
19
Reduced
27
Closed
7
Top Buys
| 1 |
Krystal Biotech
KRYS
|
$66.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$34.8M |
| 3 |
UroGen Pharma
URGN
|
$29.9M |
| 4 |
Elevance Health
ELV
|
$27.2M |
| 5 |
UnitedHealth
UNH
|
$26.9M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$21.7M |
| 2 |
Insmed
INSM
|
$20.3M |
| 3 |
Hologic
HOLX
|
$18.7M |
| 4 |
Merus
MRUS
|
$18.2M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$18M |
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Consumer Staples | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Teva Pharmaceuticals
TEVA
$21.7B
| – | – |
-450,500
| Closed | -$6.92M |
|
102
SPDR S&P Biotech ETF
XBI
$5.39B
| – | – |
0
| – | – |
|